{"organizations": [], "uuid": "94af96a79e480689e7afd356b49ffe48d96c85f6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/dicerna-alnylam-pharms/biotech-companies-alnylam-dicerna-settle-trade-secrets-case-idUSL1N1RX13O", "country": "US", "domain_rank": 408, "title": "CORRECTED-Biotech companies Alnylam, Dicerna settle trade secrets case", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-20T20:02:00.000+03:00", "replies_count": 0, "uuid": "94af96a79e480689e7afd356b49ffe48d96c85f6"}, "author": "", "url": "https://www.reuters.com/article/dicerna-alnylam-pharms/biotech-companies-alnylam-dicerna-settle-trade-secrets-case-idUSL1N1RX13O", "ord_in_thread": 0, "title": "CORRECTED-Biotech companies Alnylam, Dicerna settle trade secrets case", "locations": [], "entities": {"persons": [{"name": "dicerna", "sentiment": "negative"}, {"name": "nate raymond", "sentiment": "none"}, {"name": "tom brown", "sentiment": "none"}], "locations": [{"name": "massachusetts", "sentiment": "none"}, {"name": "woburn", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}], "organizations": [{"name": "alnylam", "sentiment": "negative"}, {"name": "alnylam pharmaceuticals inc", "sentiment": "none"}, {"name": "dicerna pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 20, 2018 / 4:43 PM / in 12 minutes CORRECTED-Biotech companies Alnylam, Dicerna settle trade secrets case Reuters Staff 1 Min Read \n(Corrects settlement amount in first paragraph to say $15 million) \nBOSTON, April 20 (Reuters) - Dicerna Pharmaceuticals Inc on Friday said it will pay $15 million plus stock to Alnylam Pharmaceuticals Inc to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments. \nThe settlement between the two biotech companies resolves a lawsuit that Alnylam filed against Dicerna in 2015. The accord came ahead of a jury trial that was set to begin on Monday in state court in Woburn, Massachusetts. (Reporting by Nate Raymond in Boston Editing by Tom Brown)", "external_links": [], "published": "2018-04-20T20:02:00.000+03:00", "crawled": "2018-04-20T20:28:21.009+03:00", "highlightTitle": ""}